tg-me.com/venture_tg/5118
Last Update:
Quadria Capital has closed its third healthcare-focused fund at $1.3 billion, surpassing its initial $800 million target. This milestone sets a new benchmark for healthcare investment in Asia, reflecting strong investor confidence in the region’s healthcare sector.
• Final close at $1.3B, exceeding the original $800M target
• Focus: Growth-stage healthcare companies across Asia, with 60% of capital earmarked for India
• Investors include development finance institutions, pension funds, insurance companies, and family offices
• Strategy: Support companies enhancing healthcare access, affordability, and quality
• Asia faces a growing demand for quality healthcare services amid population growth and rising chronic diseases
• Quadria’s fund aims to bridge gaps in healthcare infrastructure and services, particularly in underserved markets
• Investments will target sectors like hospitals, diagnostics, medical devices, and digital health
• Builds on Quadria’s track record of successful investments in companies like Concord Biotech and Medica Synergie
• Plans to leverage local expertise and partnerships to drive value creation
• Emphasis on ESG principles and impact investing to ensure sustainable growth
Quadria Capital is poised to play a pivotal role in transforming Asia’s healthcare landscape by backing innovative solutions that address critical healthcare challenges.
